O-6 EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—an open-label randomized controlled phase II study
| Autor: | Smyth, E., Mauer, M., Cella, C., Ben-Aharon, I., Piessen, G., Wyrwicz, L., Al-Haidari, G., Kanonnikoff, T. Fleitas, Boige, V., Stahl, M., Martens, U., Obermannová, R., Gomez-Martin, C., Thuss-Patience, P., Arrazubi, V., Avallone, A., Shiu, K., Collienne, M., Giraut, A., Lordick, F. |
|---|---|
| Zdroj: | In Annals of Oncology June 2023 34 Supplement 1:S182-S183 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|